Small businesses not required to register products with the FDA under new cosmetics regulations should consider doing so anyway in order to stay ahead of evolving requirements and complete work while ‘stakes are lower,’ said cosmetics software and consulting firm Good Face Project in a recent MoCRA webinar.
Modernization of Cosmetics Regulation Act (MoCRA) stakeholders should spend some time with the US Food and Drug Administration’s product listing portal, even if they are not currently required to, to stay ahead of regulations as they evolve in coming years, says The Good Face Project, Inc.
In particular, small businesses that do not need to list products and ingredients with the agency because their sales are...
Create an account to read this article
Already a subscriber?
UK consumer advocacy organization finds more than two-thirds of 34 skin care and makeup products it purchased from third party sellers on major ecommerce sites are likely fake.
What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.
While FDA fully supports the recent roadmap to reduce and eliminate animal testing, animal tests are still necessary for assessing systemic effects, says Jacqueline Corrigan-Curay, acting director for CDER, during a House Energy and Commerce Health Subcommittee hearing.
The European Commission’s Simplification Omnibus published July 8 is ‘step in right direction’ for streamlining processes and providing more legal certainty and predictability for regulations addressing cosmetics, says Cosmetics Europe.
The Personal Care Products Council identifies sunscreen regulations among federal laws that place US industry at a competitive disadvantage, in comments to the Federal Trade Commission and the US Department of Justice Antitrust Division.
A national wholesalers’ trade group is suing Oregon, claiming its EPR law, which requires producers to register, report packaging data and pay fees, is unconstitutional and overly burdensome.
OMUFA reauthorization bill including amendment with sunscreen regulation provisions passed by Senate committee, which also approved other provisions not included in House OMUFA bill.
